Showing results (561-570 of 622) with videos related to

Sort By:
Pageof 63
American Journal of Perinatology|December 16, 2018
Preterm Prelabor Rupture of Membranes: Outcomes with Expectant Management until 34 versus 35 WeeksTara A Lynch, Courtney Olson-Chen, Sarah Colihan, et al.
The Annals of Thoracic Surgery|December 5, 2017
Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist DeviceIgor Gosev, Michael S Kiernan, Peter Eckman, et al.
Human Molecular Genetics|November 5, 1997
A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43)C B Eckman, N D Mehta, R Crook, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 15, 2014
An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trialSamer S Najjar, Mark S Slaughter, Francis D Pagani, et al.
Chest|February 9, 2012
Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesGordon H Guyatt, Susan L Norris, Sam Schulman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2004
Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibodyBernhard J Hering, Raja Kandaswamy, James V Harmon, et al.
Chest|February 9, 2012
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJohn J You, Daniel E Singer, Patricia A Howard, et al.
JACC. Heart Failure|February 28, 2025
Left Atrial-to-Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT-FLOW Trial (Early Feasibility Study) 2-Year ResultsFrancesco Fioretti, Benjamin Hibbert, Peter M Eckman, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activityTimothy A Lewis, Michelle A Young, Mark P Arrington, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 30, 2006
Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau speciesChad A Dickey, Mei Yue, Wen-Lang Lin, et al.
Pageof 63